Financhill
Back

Adagio Medical Holdings Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
14

ADGM
Adagio Medical Holdings

Last Price:
2.71
Seasonality Move:
0.79%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Adagio Medical Holdings Price Quote

$2.71

Adagio Medical Holdings Key Stats

Sell
14
Adagio Medical Holdings (ADGM) is a Sell

Day range:
$2.71 - $2.75
52-week range:
$2.40 - $11.57
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.91%

Volume:
2.5K
Avg. volume:
17.3K
1-year change:
-75.05%
Market cap:
$20.4M
Revenue:
$0
EPS:
$-0.27

How Much Does Adagio Medical Holdings Make?

Data Unavailable

Is Adagio Medical Holdings Growing As A Company?

Data Unavailable

Adagio Medical Holdings Stock Price Performance

What Is Adagio Medical Holdings 52-Week High & Low?

Adagio Medical Holdings Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Adagio Medical Holdings?

Is Adagio Medical Holdings Cash Flow Positive?

  • What Is ADGM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$1M
  • What Is Adagio Medical Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.9M
  • What Is Adagio Medical Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $3M

Adagio Medical Holdings Return On Invested Capital

Data Unavailable

Adagio Medical Holdings Earnings Date & Stock Price

Adagio Medical Holdings Competitors

Adagio Medical Holdings Dividend Yield

Adagio Medical Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many ADGM shares are owned by institutional investors?
    23.1K ADGM shares are owned by institutional investors
  • How many ADGM shares are owned by insiders?
    44.2K ADGM shares are owned by insiders